Future directions for the development of Chlamydomonas-based vaccines

References

• Josefsberg JO, Buckland B. Vaccine process technology. Biotechnol. Bioeng. 109(6), 1443–1460 (2012).
   PubMed Web of Science ®Google Scholar
• Rochaix JD. Chlamydomonas reinhardtii as the photosynthetic yeast. Annu. Rev. Genet. 29, 209–230 (1995).
   PubMedGoogle Scholar
• Gutman BL, Niyogi KK. Chlamydomonas and Arabidopsis. A dynamic duo. Plant Physiol. 135(2), 607–610 (2004).
   PubMedGoogle Scholar
• Mayfield SP, Franklin SE, Lerner RA. Expression and assembly of a fully active antibody in algae. Proc. Natl Acad. Sci. U.S.A. 21, 100(2), 438–442 (2003).
   Google Scholar
• Franklin SE, Mayfield SP. Recent developments in the production of human therapeutic proteins in eukaryotic algae. Expert Opin. Biol. Ther. 5(2), 225–235 (2005).
   PubMed Web of Science ®Google Scholar
• Sun M, Qian K, Su N et al. Foot-and-mouth disease virus VP1 protein fused with cholera toxin B subunit expressed in Chlamydomonas reinhardtii chloroplast. Biotechnol. Lett. 25, 1087–1092 (2003).
   PubMed Web of Science ®Google Scholar
• Neupert J, Shao N, Lu Y, Bock R. Genetic transformation of the model green alga Chlamydomonas reinhardtii. Methods Mol. Biol. 847:35–47 (2012).
   PubMedGoogle Scholar
• Yamano T, Iguchi H, Fukuzawa H. Rapid transformation of Chlamydomonas reinhardtii without cell-wall removal. J. Biosci. Bioeng. 115(6), 691–694 (2013).
   PubMedGoogle Scholar
• Chen HC, Melis A. Marker-free genetic engineering of the chloroplast in the green microalga Chlamydomonas reinhardtii. Plant Biotechnol. J. doi: 10.1111/pbi.12073 (2013).
   Google Scholar
• Rasala BA, Mayfield SP. The microalga Chlamydomonas reinhardtii as a platform for the production of human protein therapeutics. Bioeng. Bugs. 2(1), 50–54 (2011).
   PubMedGoogle Scholar
• Rosales-Mendoza S, Paz-Maldonado LM, Soria-Guerra RE. Chlamydomonas reinhardtii as a viable platform for the production of recombinant proteins: current status and perspectives. Plant Cell. Rep. 31(3), 479–94 (2012).
   PubMedGoogle Scholar
• Franklin SE, Mayfield SP. Prospects for molecular farming in the green alga Chlamydomonas Curr. Opin. Plant Biol. 7(2), 159–65 (2004).
   PubMedGoogle Scholar
• Lössl AG, Waheed MT. Chloroplast-derived vaccines against human diseases: achievements, challenges and scopes. Plant Biotechnol. J. 9(5), 527–39 (2011).
   PubMed Web of Science ®Google Scholar
• WHO, World Malaria Report. World Health Organization (2005).
   Google Scholar
• Dauvillée D, Delhaye S, Gruyer S et al. Engineering the chloroplast targeted malarial vaccine antigens in Chlamydomonas starch granules. PLoS One 5, e15424 (2010).
   PubMed Web of Science ®Google Scholar
• Gregory JA, Li F, Tomosada LM et al. Algae-produced Pfs25 elicits antibodies that inhibit malaria transmission. PLoS One 7(5), e37179 (2012).
   PubMed Web of Science ®Google Scholar
• Jones CS, Luong T, Hannon M et al. Heterologous expression of the C-terminal antigenic domain of the malaria vaccine candidate Pfs48/45 in the green algae Chlamydomonas reinhardtii. Appl. Microbiol. Biotechnol. (2012).
   Google Scholar
• Wang XF, Brandsma M, Tremblay R et al. A novel expression platform for the production of diabetes-associated autoantigen human glutamic acid decarboxylase (hGAD65). BMC Biotechnol. 8, e87 (2008).
   PubMed Web of Science ®Google Scholar
• Bach JF, Chatenoud L. Tolerance to islet autoantigens in type 1 diabetes. Annu. Rev. Immunol. 19, 131–61 (2001).
   PubMed Web of Science ®Google Scholar
• Alexandersen S, Mowat GN. Foot-and-mouth disease: host range and pathogenesis. Curr. Top. Microbiol. Immunol. 288, 9–42 (2005).
   PubMedGoogle Scholar
• Kluytmans J, van BelkumA, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin. Microbiol. Rev. 10, 505–520 (1997).
   PubMed Web of Science ®Google Scholar
• Dreesen IA, Charpin-El Hamri G, Fussenegger M. Heat-stable oral alga-based vaccine protects mice from Staphylococcus aureusin fection. J. Biotechnol. 145, 273–280 (2010).
   PubMed Web of Science ®Google Scholar
• He DM, Qian KX, Shen GF et al. Recombination and expression of classical swine fever virus (CSFV) structural protein E2 gene in Chlamydomonas reinhardtii chroloplasts. Colloids Surf. B. Biointerfaces 55, 26–30 (2006).
   PubMedGoogle Scholar
• Nashar TO, Amin T, Marcello A, Hirst TR. Current progress in the development of the B subunits of cholera toxin and Escherichia coli heat-labile enterotoxin as carriers for the oral delivery of heterologous antigens and epitopes. Vaccine 11(2), 235–240 (1993).
   PubMedGoogle Scholar
• Demurtas OC, Massa S, Ferrante P, Venuti A, Franconi R, Giuliano GA. Chlamydomonas-derived human papillomavirus 16 e7 vaccine induces specific tumor protection. PLoS. One. 23, 8(4), e61473 (2013).
   Google Scholar
• Coragliotti AT, Beligni MV, Franklin SE, Mayfield SP. Molecular factors affecting the accumulation of recombinant proteins in the Chlamydomonas reinhardtii chloroplast. Mol. Biotechnol. 48(1), 60–75 (2011).
   PubMedGoogle Scholar
• Cerutti H, Johnson AM, Gillham NW, Boynton JE. Epigenetic Silencing of a Foreign Gene in Nuclear Transformants of Chlamydomonas. Plant Cell. 9(6), 925–945 (1997).
   PubMedGoogle Scholar
• Leon R, Fernandez E. Nuclear transformation of eukaryotic microalgae: historical overview, achievements and problems. Adv. Exp. Med. Biol. 616, 1–11 (2007).
   PubMedGoogle Scholar
• Shaver S, Casas-Mollano JA, Cerny RL, Cerutti H. Origin of the polycomb repressive complex 2 and gene silencing by an E(z) homolog in the unicellular alga Chlamydomonas. Epigenetics 5(4), 301–312 (2010).
   PubMed Web of Science ®Google Scholar
• Wu-Scharf D, Jeong B, Zhang C, Cerutti H. Transgene and transposon silencing in Chlamydomonas reinhardtii by a DEAH-box RNA helicase. Science 290(5494), 1159–1162 (2000).
   PubMed Web of Science ®Google Scholar
• Rasala BA, Lee PA, Shen Z et al. Robust expression and secretion of Xylanase1 in Chlamydomonas reinhardtii by fusion to a selection gene and processing with the FMDV 2A peptide. PLoS One 7(8), e43349 (2012).
   PubMed Web of Science ®Google Scholar
• Ryan MD, King AM, Thomas GP. Cleavage of foot-and-mouth disease virus polyprotein is mediated by residues located within a 19 amino acid sequence. J. Gen. Virol. 72(Pt 11), 2727–2732 (1991).
   PubMedGoogle Scholar
• Donnelly ML, Hughes LE, Luke G et al. The ‘cleavage’ activities of foot-and-mouth disease virus 2A site-directed mutants and naturally occurring ‘2A-like’ sequences. J. Gen. Virol. 82, 1027–1041 (2001).
   PubMed Web of Science ®Google Scholar
• Holmgren J, Lycke N, Czerkinsky C. Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems. Vaccine 11(12), 1179–1184 (1993).
   PubMed Web of Science ®Google Scholar
• Arai Y, Shikanai T, Doi Y, Yoshida S, Yamaguchi I, Nakashita H. Production of polyhydroxybutyrate by polycistronic expression of bacterial genes in tobacco plastid. Plant Cell. Physiol. 45(9), 1176–1184 (2004).
   PubMed Web of Science ®Google Scholar
• Lauersen KJ, Berger H, Mussgnug JH et al. Efficient recombinant protein production and secretion from nuclear transgenes in Chlamydomonas reinhardtii. J. Biotechnol. pii: S0168–1656 (12)00685-2 (2012).
   PubMedGoogle Scholar
• Kliphuis AM, Klok AJ, Martens DE, Lamers PP, Janssen M, Wijffels RH. Metabolic modeling of Chlamydomonas reinhardtii: energy requirements for photoautotrophic growth and maintenance. J. Appl. Phycol. 24(2), 253–266 (2012).
   PubMedGoogle Scholar
• Mestecky J, Nguyen H, Czerkinsky C et al. Oral immunization: an update. Curr. Opin. Gastroenterol. 24, 713–719 (2008).
   PubMed Web of Science ®Google Scholar
• Fujkuyama Y, Tokuhara D, Kataoka K et al. Novel vaccine development strategies for inducing mucosal immunity. Expert Rev. Vaccines 11(3), 367–379 (2012).
   PubMed Web of Science ®Google Scholar
• Gebril A, Alsaadi M, Acevedo R et al. Optimizing efficacy of mucosal vaccines. Expert Rev. Vaccines 11(9), 1139–1155 (2012).
   PubMed Web of Science ®Google Scholar
• Pavot V, Rochereau N, Genin C et al. New insights in mucosal vaccine development. Vaccine 30, 142–154 (2012).
   PubMed Web of Science ®Google Scholar
• Coffman RL, Sher A, Seder RA. Vaccine adjuvants: putting innate immunity to work. Immunity. 33, 492–503 (2010).
   PubMed Web of Science ®Google Scholar
• Reed SG, Bertholet S, Coler RN et al. New horizons in adjuvants for vaccine development. Trends Immunol. 30, 23–32 (2009).
   PubMed Web of Science ®Google Scholar
• Babai I, Samira S, Barenholz Y et al. A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. II. Induction of TH1 and TH2 responses in mice. Vaccine 17, 1239–1250 (1999).
   PubMed Web of Science ®Google Scholar
• Kong Q, Richter L, Yang YF et al. Oral immunization with hepatitis B surface antigen expressed in transgenic plants. Proc. Natl Acad. Sci. U. S. A. 98, 11539–11544 (2001).
   PubMed Web of Science ®Google Scholar
• Belyakov IM, Ahlers JD. What role does the route of immunization play in the generation of protective immunity against mucosal pathogens? J. Immunol. 183(11), 6883–6892 (2009).
   PubMed Web of Science ®Google Scholar
• Schepetkin IA, Quinn MT. Botanical polysaccharides: macrophage immunomodulation and therapeutic potential. Int. Immunopharmacol. 6(3), 317–333 (2006).
   PubMed Web of Science ®Google Scholar
• Guzmán S, Gato A, Lamela M et al. Anti-inflammatory and immunomodulatory activities of polysaccharide from Chlorella stigmatophora and Phaeodactylum tricornutum. Phytother. Res. 17(6), 665–670 (2003).
   PubMedGoogle Scholar
• Liu BH, Lee YK Effect of total secondary carotenoids extracts from Chlorococcum sp. on Helicobacter pylori-infected BALB/c mice. Int. Immunopharmacol. 3(7), 979–986 (2003).
   PubMedGoogle Scholar
• Pugh N, Ross SA, ElSohly HN et al. Isolation of three high molecular weight polysaccharide preparations with potent immunostimulatory activity from Spirulina platensis, Aphanizomenon flos-aquae and Chlorella pyrenoidosa. Planta Med. 67, 737–742 (2001).
   PubMed Web of Science ®Google Scholar
• Raychaudhuri S, Morrow WJ. Can soluble antigens induce CD8+ cytotoxic T-cell responses? A paradox revisited. Immunol. Today. 14(7), 344–348 (1993).
   PubMedGoogle Scholar
• Foged C, Hansen J, Agger EM. License to kill: Formulation requirements for optimal priming of CD8(+) CTL responses with particulate vaccine delivery systems. Eur. J. Pharm. Sci. 45(4), 482–491 (2012).
   PubMed Web of Science ®Google Scholar
• Remondo C, Cereda V, Mostböck S et al. Human dendritic cell maturation and activation by a heat-killed recombinant yeast (Saccharomyces cerevisiae) vector encoding carcinoembryonic antigen. Vaccine 27(7), 987–994 (2009).
   PubMed Web of Science ®Google Scholar
• Zhang T, Yang H, Wang R et al. Oral administration of myostatin-specific whole recombinant yeast Saccharomyces cerevisiae vaccine increases body weight and muscle composition in mice. Vaccine 29(46), 8412–8416 (2011).
   PubMedGoogle Scholar
• Zhang T, Sun L, Xin Y et al. A vaccine grade of yeast Saccharomyces cerevisiae expressing mammalian myostatin. BMC Biotechnol. 12(1), 97 (2012).
   PubMedGoogle Scholar
• Stubbs AC, Martin KS, Coeshott C et al. Whole recombinant yeast vaccine activates dendritic cells and elicits protective cell-mediated immunity. Nat. Med. 7(5), 625–629 (2001).
   PubMed Web of Science ®Google Scholar
• Newman SL, Holly A. Candida albicans is phagocytosed, killed, and processed for antigen presentation by human dendritic cells. Infect. Immun. 69(11), 6813–6822 (2001).
   PubMedGoogle Scholar
• Underhill DM, Ozinsky A. Phagocytosis of microbes: complexity in action. Annu. Rev. Immunol. 20, 825–852 (2002).
   PubMed Web of Science ®Google Scholar
• Ozinsky A, Underhill DM, Fontenot JD et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc. Natl Acad. Sci. U.S.A.97 (25), 13766–13771 (2000).
   PubMed Web of Science ®Google Scholar
• Kaisho T, Akira S. Dendritic-cell function in Toll-like receptor- and MyD88-knockout mice. Trends Immunol. 22 (2), 78–83 (2001).
   PubMedGoogle Scholar
• Xia Y, Vetvicka V, Yan J et al. The beta-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells. J. Immunol. 162 (4), 2281–2290 (1999).
   PubMedGoogle Scholar
• Engering AJ, Cella M, Fluitsma D et al. The mannose receptor functions as a high capacity and broad specificity antigen receptor in human dendritic cells. Eur. J. Immunol. 27(September (9)), 2417–2425 (1997).
   PubMedGoogle Scholar
• Colella TA, Bullock TN, Russell LB et al. Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: implications for tumor immunotherapy. J. Exp. Med. 191(April (7), 1221–1232 (2000).
   PubMedGoogle Scholar
• Tan MC, Mommaas AM, Drijfhout JW et al. Mannose receptor-mediated uptake of antigens strongly enhances HLA class II-restricted antigen presentation by cultured dendritic cells. Eur. J. Immunol. 27 (9), 2426–2435 (1997).
   PubMed Web of Science ®Google Scholar
• Miller DH, Mellman IS, Lamport DT et al. The chemical composition of the cell wall of Chlamydomonas gymnogamaand the concept of a plant cell wall protein. J. Cell Biol. 63(2 Pt 1), 420–429 (1974).
   PubMedGoogle Scholar
• Roberts K. Crystalline glycoprotein cell walls of algae: their structure, composition and assembly. Philos. Trans. R. Soc. Lond. B. 268, 129–146 (1974).
   PubMed Web of Science ®Google Scholar
• Bollig K, Lamshöft M, Schweimer K et al. Structural analysis of linear hydroxyproline-bound O-glycans of Chlamydomonas reinhardtii: conservation of the inner core in Chlamydomonas and land plants. Carbohydr. Res. 342, 2557–2566 (2007).
   PubMedGoogle Scholar
• Eder M, Tenhaken R, Driouich A et al. Occurrence and characterization of arabinogalactan-like proteins and hemicelluloses in Micrasterias (Streptophyta). J. Phycol. 44, 1221–1234 (2008).
   PubMedGoogle Scholar
• Estevez JM, Fernández PV, Kasulin L et al. Chemical and in situ characterization of macromolecular components of the cell walls from the green seaweed Codium fragile. Glycobiology 19, 212–228 (2009).
   PubMed Web of Science ®Google Scholar
• Dunn EK, Shoue DA, Huang X et al. Spectroscopic and biochemical analysis of regions of the cell wall of the unicellular ‘mannan weed,’ Acetabularia acetabulum. Plant Cell Physiol. 48, 122–133 (2007).
   PubMedGoogle Scholar
• Popper ZA, Tuohy MG. Beyond the green: understanding the evolutionary puzzle of plant and algal cell walls. Plant Physiol.153(2), 373–383 (2010).
   PubMedGoogle Scholar
• Domozych DS, Ciancia M, Fangel JU et al. The cell walls of green algae: a journey through evolution and diversity. Front. Plant. Sci. 3, 82 (2012).
   PubMed Web of Science ®Google Scholar